Phuong Khanh Morrow
Known title: DirectorCIK: 0001928989
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
CRISPR Therapeutics to Share New Data at AHA and ACR 2026. CRISPR Therapeutics announced it will present late-breaking data at the American Heart Association and American College of Rheumatology conferences in 2026. These upcoming presentations are key events for the company, as they will provide new clinical insights into its treatments for heart and autoimmune conditions. The stock is currently trading near its 52-week low, making these data releases a significant factor for investors watching the company's progress.
Transaction History
| LNTH | ▲ Buy | Grant | 4,137 | $0 | 5/14/2026 | View on chart |
| LNTH | ▲ Buy | Grant | 2,537 | $0 | 5/14/2025 | View on chart |
| LNTH | ▲ Buy | Grant | 563 | $0 | 2/7/2025 | View on chart |
| CRSP | ▼ Sell | Tax Withholding | 2,527 | $167K | 5/24/2023 | View on chart |
| CRSP | ▲ Buy | Option Exercise | 6,938 | — | 5/23/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Lantheus Holdings receives Mizuho downgrade to neutral
Lantheus Holdings was downgraded to neutral by Mizuho, which also cut its price target to $109. The downgrade appeared alongside other recent analyst cuts highlighted in a Benzinga roundup of top downgrades. The new target sits near the current analyst consensus of $107.22 and close to the stock’s 52‑week high, while the RSI is around the midpoint.
Lantheus Holdings receives Mizuho downgrade to neutral. Lantheus Holdings was downgraded to neutral by Mizuho, which also cut its price target to $109. The downgrade appeared alongside other recent analyst cuts highlighted in a Benzinga roundup of top downgrades. The new target sits near the current analyst consensus of $107.22 and close to the stock’s 52‑week high, while the RSI is around the midpoint.